Cellebrite DI Ltd.

NasdaqGS:CLBT Voorraadrapport

Marktkapitalisatie: US$3.8b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Cellebrite DI Beheer

Beheer criteriumcontroles 3/4

De CEO Cellebrite DI's is Yossi Carmil, benoemd in Jan2005, heeft een ambtstermijn van 19.75 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 2.15M, bestaande uit 22.2% salaris en 77.8% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 2.26% van de aandelen van het bedrijf, ter waarde $ 83.12M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.1 jaar en 3.2 jaar.

Belangrijke informatie

Yossi Carmil

Algemeen directeur

US$2.1m

Totale compensatie

Percentage CEO-salaris22.2%
Dienstverband CEO19.8yrs
Eigendom CEO2.3%
Management gemiddelde ambtstermijn2.1yrs
Gemiddelde ambtstermijn bestuur3.2yrs

Recente managementupdates

There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased

Sep 10
There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased

Recent updates

There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased

Sep 10
There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased

Cellebrite: Rating Downgrade As Valuation Has Caught Up

Aug 27

Cellebrite DI Ltd.'s (NASDAQ:CLBT) 29% Share Price Surge Not Quite Adding Up

Aug 17
Cellebrite DI Ltd.'s (NASDAQ:CLBT) 29% Share Price Surge Not Quite Adding Up

Why We're Not Concerned About Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price

Jun 25
Why We're Not Concerned About Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price

Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?

May 21
Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?

Cellebrite: Big Fish In A Small Pond

Apr 29

Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Mar 14
Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

Feb 18
Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Jan 28
There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Is Cellebrite DI Ltd. (NASDAQ:CLBT) Trading At A 39% Discount?

Nov 04
Is Cellebrite DI Ltd. (NASDAQ:CLBT) Trading At A 39% Discount?

Calculating The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

May 26
Calculating The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

We Ran A Stock Scan For Earnings Growth And Cellebrite DI (NASDAQ:CLBT) Passed With Ease

Apr 29
We Ran A Stock Scan For Earnings Growth And Cellebrite DI (NASDAQ:CLBT) Passed With Ease

Is Now The Time To Look At Buying Cellebrite DI Ltd. (NASDAQ:CLBT)?

Mar 16
Is Now The Time To Look At Buying Cellebrite DI Ltd. (NASDAQ:CLBT)?

Cellebrite DI Ltd. (NASDAQ:CLBT) Held Back By Insufficient Growth Even After Shares Climb 33%

Feb 16
Cellebrite DI Ltd. (NASDAQ:CLBT) Held Back By Insufficient Growth Even After Shares Climb 33%

Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Feb 09
Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Oct 18
Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Cellebrite: A Niche Company With A Large TAM

Sep 30

Cellebrite DI Lowers Sights For 2022

Aug 30

Analyse CEO-vergoeding

Hoe is Yossi Carmil's beloning veranderd ten opzichte van Cellebrite DI's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$103m

Mar 31 2024n/an/a

-US$112m

Dec 31 2023US$2mUS$477k

-US$81m

Sep 30 2023n/an/a

-US$64m

Jun 30 2023n/an/a

-US$42m

Mar 31 2023n/an/a

US$20m

Dec 31 2022US$2mUS$490k

US$116m

Sep 30 2022n/an/a

US$165m

Jun 30 2022n/an/a

US$152m

Mar 31 2022n/an/a

US$122m

Dec 31 2021US$2mUS$502k

US$70m

Compensatie versus markt: De totale vergoeding ($USD 2.15M ) Yossi } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.79M ).

Compensatie versus inkomsten: De vergoeding van Yossi is gestegen terwijl het bedrijf verliesgevend is.


CEO

Yossi Carmil (56 yo)

19.8yrs

Tenure

US$2,147,000

Compensatie

Mr. Yossi Carmil serves as Chief Executive Officer at Cellebrite DI Ltd. since 2005 and is its Director since June 2019. He is Founder of Cellebrite DI Ltd.Mr. Carmil served as Global Co-Chief Executive O...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Yossi Carmil
Founder19.8yrsUS$2.15m2.26%
$ 85.4m
Dana Gerner
Chief Financial Officer10.4yrsUS$1.19mgeen gegevens
Ronnen Armon
Chief Products & Technologies Officer4.3yrsUS$1.03mgeen gegevens
Leeor Ben-Peretz
Chief Strategy Officer7.7yrsUS$895.00kgeen gegevens
Thomas Hogan
Executive Chairman1.2yrsgeen gegevensgeen gegevens
Andrew Kramer
Vice President of Investor Relationsno datageen gegevensgeen gegevens
Ayala Shapira
General Counsel & Chief Compliance Officer2.1yrsgeen gegevensgeen gegevens
David Gee
Chief Marketing Officerless than a yeargeen gegevensgeen gegevens
Zohar Tadmor-Eilat
Chief People Officer1.8yrsgeen gegevensgeen gegevens
Marcus Jewell
Global Chief Revenue Officerless than a yeargeen gegevensgeen gegevens

2.1yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CLBT wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.1 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Yossi Carmil
Founder5.3yrsUS$2.15m2.26%
$ 85.4m
Thomas Hogan
Executive Chairman1.2yrsgeen gegevensgeen gegevens
Dafna Gruber
Independent External Director3.2yrsgeen gegevensgeen gegevens
Adam Clammer
Lead Independent Director3.2yrsgeen gegevens0.37%
$ 13.9m
Mark Ferrer
Independent Directorless than a yeargeen gegevensgeen gegevens
Brandon Van Buren
Independent Director1.4yrsgeen gegevensgeen gegevens
Elly Keinan
Independent Director4.1yrsgeen gegevensgeen gegevens
Nadine Baudot-Trajtenberg
Independent External Director3.2yrsgeen gegevensgeen gegevens
Yonatan Domnitz
Independent Director4.5yrsgeen gegevensgeen gegevens
Ryusuke Utsumi
Independent Director4.5yrsgeen gegevensgeen gegevens
Koby Huberman
Advisory Board Memberno datageen gegevensgeen gegevens
Barbara Grewe
Independent Directorless than a yeargeen gegevensgeen gegevens

3.2yrs

Gemiddelde duur

58.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CLBT wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.2 jaar).